Impella usage rate increases, so do mortality, bleeding risks
29 Nov 2019
byAudrey Abella
An upsurge in the use of the Impella device has been observed in individuals with acute myocardial infarction complicated by cardiogenic shock (AMI-CS) undergoing percutaneous coronary intervention (PCI); however, mortality and bleeding rates also increased, according to US data presented at AHA 2019.
Impella usage rate increases, so do mortality, bleeding risks
29 Nov 2019